Physician profile
Ranjith Babu
NPI 1205271525
$12,008.18
in general payments reported to CMS, 2019-2025
31 companies · $3,250 in 2025
The $3,250 reported for 2025 was more than what 75% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $932 · 2022: $1,458 · 2023: $1,474 · 2024: $4,894 · 2025: $3,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,225 · Food and Beverage: $3,501 · Travel and Lodging: $1,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,225.00 |
| Food and Beverage | $3,500.85 |
| Travel and Lodging | $1,892.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,605.26 | 2022-2025 | Surpass Evolve |
| Medtronic, INC. | $3,291.75 | 2021-2025 | Pipeline, Strata, Spiderfx |
| Rapid Medical LTD | $722.38 | 2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Gt Medical Technologies, INC | $708.76 | 2022-2024 | Gammatile, Gammatile |
| Highridge Medical LLC | $391.65 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Brainlab, INC. | $285.94 | 2021-2023 | Image Guided Surgical Device |
| Integra Lifesciences Corporation | $224.83 | 2022-2023 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Monteris Medical Corporation | $220.73 | 2022-2024 | Neuroblate |
| Depuy Synthes Sales INC. | $220.25 | 2023-2024 | Sentio, Teligen, Symphony |
| Spinefrontier, INC. | $194.43 | 2024 | Sijfuse |
| Microtransponder, INC. | $186.94 | 2025 | |
| Boston Scientific Corporation | $151.68 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Omniscient Neurotechnology America LTD | $118.10 | 2023 | Quicktome |
| Centinel Spine, LLC | $101.73 | 2022 | |
| Csl Behring | $98.92 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $95.50 | 2025 | Airsupra |
| Cordis US Corp. | $58.32 | 2023-2025 | Precise Pro Rx, Angioguard |
| Orthofix Medical, INC. | $37.57 | 2024-2025 | Spinal-Stim, Cervical-Stim |
| Abbott Laboratories | $36.81 | 2024-2025 | Eterna |
| Ucb, INC. | $33.02 | 2023 | Briviact |
| Aesculap, INC. | $29.61 | 2021 | |
| Bioventus LLC | $25.28 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.59 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.42 | 2022 | |
| Sanara Medtech INC. | $23.57 | 2023 | Celleraterx |
| Djo, LLC | $22.27 | 2024 | Cmf |
| Ethicon US, LLC | $15.77 | 2023 | Vistaseal, Surgiflo Hemostatic Matrix, Dermabond Prineo |
| Globus Medical, INC. | $15.59 | 2023 | Quartex |
| Microvention, INC. | $14.54 | 2024 | Lvis Junior |
| Pfizer INC. | $14.45 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $13.52 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjith Babu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.